aap Implantate AG/€AAQ1
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About aap Implantate AG
aap Implantate AG is a medical technology company based in Berlin, Germany, specializing in the development, manufacturing, and marketing of trauma products for orthopedics. Its core offerings include the LOQTEQ® anatomical plating system and a range of cannulated screws designed for fracture treatment. The company is also advancing technologies such as antibacterial silver coating and magnesium-based implants to address unmet needs in trauma care. Founded in 1990, aap Implantate AG operates directly in Germany and through a network of distributors in approximately 25 countries, with a hybrid distribution strategy in the United States via its subsidiary, aap Implants Inc. In 2023, the company established a research and development and production headquarters in Suzhou New District, China, to conduct clinical trials on high-end silver ion anti-infection implants. This strategic expansion aims to enhance its presence in the Chinese market and leverage the region's favorable business environment.
- Ticker
- €AAQ1
- Sector
- Health
- Primary listing
- XETRA
- Employees
- 105
- Headquarters
- Berlin, Germany
- Website
- www.aap.de
AAQ1 Metrics
BasicAdvanced
€19M
-
-€0.19
0.28
-
Price and volume
Market cap
€19M
Beta
0.28
52-week high
€2.10
52-week low
€1.30
Average daily volume
1.6K
Financial strength
Current ratio
2.067
Quick ratio
0.765
Long term debt to equity
0.4
Total debt to equity
0.486
Interest coverage (TTM)
-18.60%
Profitability
EBITDA (TTM)
-1.627
Gross margin (TTM)
88.59%
Net profit margin (TTM)
-22.36%
Operating margin (TTM)
-22.71%
Effective tax rate (TTM)
0.58%
Revenue per employee (TTM)
€120,000
Management effectiveness
Return on assets (TTM)
-11.52%
Return on equity (TTM)
-31.10%
Valuation
Price to revenue (TTM)
1.637
Price to book
2.47
Price to tangible book (TTM)
2.48
Price to free cash flow (TTM)
-8.973
Free cash flow yield (TTM)
-11.14%
Free cash flow per share (TTM)
-0.158
Growth
Revenue change (TTM)
1.82%
Earnings per share change (TTM)
-35.93%
3-year revenue growth (CAGR)
1.06%
10-year revenue growth (CAGR)
0.19%
3-year earnings per share growth (CAGR)
-14.45%
10-year earnings per share growth (CAGR)
-22.84%
AAQ1 Financial Performance
Revenues and expenses
AAQ1 Earnings Performance
Company profitability
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.